Back to Top
Mogamulizumab Biosimilar - Biotin Research Grade
Mogamulizumab Biosimilar - Research Grade: Biotin
Unconjugated Product:Mogamulizumab Biosimilar - Research Grade
Conjugate:Biotin
Target:CD194
Clone:n/a
Isotype:Human IgG1κ
Other Names:Receptor tyrosine-protein kinase erbB-2, MLN 19, HER2, HER2/neu
Host:CHO Cells
Species Reactivity:Human
Specificity:Detects human ErbB2.
Background:Mogamulizumab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Mogamulizumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary).
Concentration:0.5 mg/ml
Formulation:This Biotin conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Storage:This Biotin conjugate is stable when stored at 2-8°C. Do not freeze.
Applications:Flow Cytometry, ELISA
Application Notes:Each investigator should determine their own optimal working dilution for specific applications.
Use: ichorbio's trastuzumab biosimilar is for research use only (RUO). Isotype Control:| Concentration | 7.34mg/ml |
|---|---|
| isotype | Human IgG1κ |
| Host | CHO Cells |
Write Your Own Review
Who Viewed This Also Viewed
